Name
osaühing Häädemeeste Apteek
Registry code
10295249
VAT number
EE100660434
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
14.10.1997 (26)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
46181 - Agents specialised in the sale of other particular products 47731 - Dispensing chemist in specialised stores
293 896 €
-17 373 €
-6%
3 254 €
(estimate is approximate)
87 982 €
1
Submitted
No tax arrears
-20%
-12%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Andrus Soopalu 28.05.1962 (62) | 100% - 2 556.00 EUR | Board member | Direct ownership |
| 2019 09.05.2020 | 2020 22.04.2021 | 2021 31.05.2022 | 2022 07.06.2023 | 2023 03.04.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 291 231 € | 375 018 € | 374 858 € | 350 923 € | 293 896 € |
| Net profit (loss) for the period | 1 065 € | 8 929 € | 22 773 € | -9 504 € | -17 373 € |
| Profit Margin | 0% | 2% | 6% | -3% | -6% |
| Current Assets | 45 241 € | 52 316 € | 160 920 € | 138 354 € | 122 900 € |
| Fixed Assets | 102 596 € | 101 986 € | 2 156 € | 16 128 € | 16 599 € |
| Total Assets | 147 837 € | 154 302 € | 163 076 € | 154 482 € | 139 499 € |
| Current Liabilities | 64 680 € | 62 216 € | 48 217 € | 49 127 € | 51 517 € |
| Non Current Liabilities | 0 € | 0 € | 0 € | 0 € | 0 € |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 83 157 € | 92 086 € | 114 859 € | 105 355 € | 87 982 € |
| Employees | 1 | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 69 309.79 € | 6 749.89 € | 5 947.43 € | 1 |
| 2023 Q4 | 78 765.54 € | 6 223.65 € | 5 236.09 € | - |
| 2023 Q3 | 79 092.67 € | 5 830.78 € | 5 121.6 € | 1 |
| 2023 Q2 | 69 182.71 € | 4 655.16 € | 4 305.41 € | 1 |
| 2023 Q1 | 69 728.51 € | 5 316.43 € | 4 745.25 € | 1 |
| 2022 Q4 | 69 516.95 € | 5 131.81 € | 4 734.5 € | 1 |
| 2022 Q3 | 100 853.39 € | 5 473.58 € | 4 261.23 € | 1 |
| 2022 Q2 | 99 207.1 € | 4 165.51 € | 4 240.82 € | 1 |
| 2022 Q1 | 85 789.78 € | 5 802.8 € | 5 012.8 € | 1 |
| 2021 Q4 | 92 245.54 € | 5 417.85 € | 4 091.19 € | 1 |
| 2021 Q3 | 102 246.09 € | 6 232.59 € | 4 765.68 € | 1 |
| 2021 Q2 | 88 424.5 € | 5 047.87 € | 3 906.4 € | 1 |
| 2021 Q1 | 80 955.41 € | 5 598.36 € | 4 091.19 € | 1 |
| 2020 Q4 | 103 477.24 € | 5 562.48 € | 4 091.19 € | 1 |
| 2020 Q3 | 74 220.76 € | 6 081.26 € | 4 313.49 € | 1 |
| 2020 Q2 | 114 182.04 € | 7 021.58 € | 4 825.73 € | 1 |
| 2020 Q1 | 71 993.13 € | 5 012.08 € | 4 045.25 € | 2 |
